Tag

Supply Challenges

All articles tagged with #supply challenges

Plug Power's Stock Plummets on Unprecedented Supply Challenges and Q3 Earnings Miss
business2 years ago

Plug Power's Stock Plummets on Unprecedented Supply Challenges and Q3 Earnings Miss

Plug Power's stock dropped over 25% after reporting a wider loss and revenue miss for the third quarter. The company cited "unprecedented supply challenges" in the hydrogen network in North America, which have impacted its direct cost of services and fleet upgrades. Plug Power expects the hydrogen-supply challenge to be temporary and plans to tap capital markets for funding. The company also pushed out plant timelines and withdrew its 2023 revenue guidance. Shares of Plug Power have declined 52% this year.

Tech Giant Oracle Faces Deepening Slump Despite AI Event
business2 years ago

Tech Giant Oracle Faces Deepening Slump Despite AI Event

Oracle stock fell 6% after hosting an AI forum, as analysts noted ongoing supply challenges in building out AI infrastructure. The event aimed to provide product updates to customers of Oracle Cloud Infrastructure (OCI), which is crucial for Oracle's expansion in the cloud market. Analysts remain positive on Oracle stock, believing that the AI lift to OCI will come, despite the supply constraints. However, JPMorgan analysts caution that the conversion of bookings to revenue may take longer than expected due to barriers in data center construction. Oracle stock has been on a downward trend since reporting earnings in September, but it still maintains a strong Composite Rating and is listed on the IBD Tech Leaders list.

"Challenges and Frustrations Surround RSV Antibody Shot Rollout for Babies"
health2 years ago

"Challenges and Frustrations Surround RSV Antibody Shot Rollout for Babies"

Pediatricians are facing challenges in obtaining the RSV antibody shot for babies, which has been approved by the CDC and FDA to prevent respiratory syncytial virus in infants. The shot, developed by AstraZeneca and Sanofi, is expected to reduce hospital admissions for RSV in children under 1 year old. However, the lack of infrastructure and high cost of nearly $500 per dose are hindering its rollout. Pediatricians are frustrated and concerned about missed opportunities to protect children from RSV, while insurance companies are focused on the financial aspect. The American Academy of Pediatrics has urged federal leaders to ensure widespread and equitable distribution of the shot.